RMC-6236

· Revolution Medicines, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for RMC-6236, covering 2025-11-12 to 2025-11-12. Get the full timeline:

Most recent: Clinical Trial Update: Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS [Phase 1, Phase 2]